Clinical pharmacology of vinzolidine
β Scribed by Willi Kreis; Daniel R Budman; Philip Schulman; Jean Freeman; Anne Greist; Robert L. Nelson; Mary Marks; Lydia Kevill
- Publisher
- Springer
- Year
- 1986
- Tongue
- English
- Weight
- 424 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Methotrexate (MTX), a potent folate antagonist by virtue of its ability to inhibit the enzyme dihydrofolate reductase [1], continues to be a useful cancer chemotherapeutic agent [2]. Information not only on its mechanism of action, but also its pharmacology has led to improved dosage sc
Animal work has shown that carvedilol is a nonselective beta-blocking drug. It has a vasodilator action from alpha-receptor blockade, but there is evidence that it has further action to relax smooth muscle, possibly from calcium channel antagonism. Carvedilol is lipid soluble and 25% bioavailable, a